Darvocet-N 50: Historical Uses, Ingredients, and Safety Information

Darvocet-N 50 was a prescription combination medication formerly used for the relief of mild to moderate pain. It contained two active ingredients: propoxyphene napsylate 50mg and acetaminophen 325mg per tablet. Although it was once prescribed for pain management, the product is no longer marketed in the United States. Its withdrawal followed evidence that propoxyphene could cause potentially serious or fatal abnormalities in heart rhythm, even at recommended doses.

What Was Darvocet-N 50?

Darvocet-N 50 combined an opioid pain reliever with acetaminophen, a non-opioid analgesic that can also reduce fever. Propoxyphene acted on the central nervous system to alter the perception of pain, while acetaminophen provided an additional pain-relieving effect.

The number 50 referred to the amount of propoxyphene napsylate in each tablet, not the total weight of both active ingredients. Each tablet also contained 325mg of acetaminophen. This distinction is important when interpreting historical medication records or archived prescribing information.

Historical Medical Uses

Darvocet-N 50 was historically prescribed for mild to moderate pain. Healthcare professionals evaluated a patient’s symptoms, medical history, and other medications before determining whether this combination was appropriate.

Its opioid component could cause sedation, impaired alertness, physical dependence, and misuse. Acetaminophen also carried a risk of serious liver injury when excessive amounts were taken, particularly when patients unknowingly combined multiple acetaminophen-containing products.

The former indication and historical prescribing information should not be interpreted as a recommendation to use the discontinued medication today. People experiencing pain should consult a healthcare professional about currently available treatment options appropriate to their condition.

Why Was Darvocet Withdrawn?

In November 2010, the U.S. Food and Drug Administration requested the withdrawal of propoxyphene-containing products, including Darvocet, after reviewing evidence of potentially dangerous heart-rhythm abnormalities. The agency concluded that the risks outweighed the benefits for pain relief.

The concern was significant because these cardiac effects could occur even when the medication was used at therapeutic doses. Serious rhythm disturbances can interfere with the heart’s ability to pump blood effectively and may become life-threatening.

Darvocet-N 50 and other propoxyphene-containing products were subsequently discontinued in the United States. The medication should not be presented as a currently approved, routinely available U.S. treatment.

Historical Side Effects and Safety Risks

Reported adverse effects associated with propoxyphene-containing medicines included nausea, vomiting, dizziness, drowsiness, and constipation. More serious concerns included respiratory depression, overdose, dependence, and dangerous cardiac effects.

Combining an opioid with alcohol, sedatives, or other central nervous system depressants could increase the risk of profound sedation and breathing difficulties. Excessive acetaminophen exposure could also damage the liver.

These historical risks are relevant when reviewing old prescriptions or medical records. Anyone who believes they may have taken a propoxyphene-containing medicine and is experiencing fainting, an abnormal heartbeat, or difficulty breathing should seek urgent medical attention.

Understanding the Former Formulation

The historical Darvocet-N 50 formulation contained propoxyphene napsylate 50mg and acetaminophen 325mg. It was different from Darvocet-N 100, which contained higher quantities of both ingredients. The name alone should therefore not be used to infer the precise composition of every historical Darvocet product.

When reviewing an old medicine label, check the complete product name, listed ingredients, and strength. Do not use unidentified or leftover tablets based on appearance or an outdated prescription.

Current Pain-Management Considerations

People seeking treatment for pain should discuss their symptoms with a qualified healthcare professional. The most suitable option depends on the cause and severity of the pain, other health conditions, current medications, and individual risk factors.

A clinician can discuss currently available treatments and explain their expected benefits, possible side effects, and precautions. Never substitute a discontinued medicine for another medication without professional guidance.

Conclusion

Darvocet-N 50 was a historical prescription combination containing propoxyphene napsylate 50mg and acetaminophen 325mg. It was withdrawn from the U.S. market because of serious cardiac safety concerns. Its former uses and formulation may be relevant to historical medication research, but the product should not be represented as a currently marketed U.S. treatment. Consult a healthcare professional for advice about present-day pain management.